WMed helping bring awareness with COPD National Action Plan 09/01/2018 majac COPD The COPD National Action Plan is the way to bring that awareness. Hess says most people don’t know the warning signs or risks and shrug off the …
Study: Prescribers Unaware of Comorbidity of Nonselective Beta Blockers for Patients With COPD … 08/31/2018 majac COPD The pharmacists in the study identified 827 asthma/COPD patients who used NS ??blockers. Of these patients, the researchers selected 153 NS …
Global Asthma & COPD Market 2018 – GSK, Novartis, Merck, Abbott, Boehringer Ingelheim … 08/30/2018 majac COPD Global Asthma & COPD Market 2018 Analysis Report audits a Market Regions, Product Categories, with Sales, Business Revenue, Goods cost, …
A breath of fresh air for chronic lung disease sufferers in low-income countries 08/29/2018 majac COPD According to the World Health Organization, more than 250 million people around the world suffer from chronic obstructive pulmonary disease (COPD) …
Latest Research Report on Chronic Obstructive Pulmonary Disorder (COPD) Market Enhancement … 08/28/2018 majac COPD Global Chronic Obstructive Pulmonary Disorder (COPD) Market by Manufacturers, Regions, Type and Application, Forecast to 2023; This report …
Inhaled corticosteroids for chronic obstructive pulmonary disease: what is their role in therapy? 08/27/2018 majac COPD Abstract: Inhaled corticosteroids (ICSs) are a mainstay of COPD treatment for patients with a history of exacerbations. Initial studies evaluating their …
Lung cancer in non-smokers on the rise: what does this mean? 08/26/2018 majac COPD Chronic obstructive pulmonary disease (COPD), characterised by poor airflow to the lungs, has been associated with smokers. But, many experts told …
5 Things to Know About the Environment and Respiratory Health 08/25/2018 majac COPD Here are 5 things to know about respiratory health, including diseases like asthma and chronic obstructive pulmonary disease (COPD), and the …
AstraZeneca’s COPD drug fails to beat out GSK rival 08/24/2018 majac COPD AstraZeneca’s lung drug Bevespi Aerosphere failed to beat a rival treatment from GlaxoSmithKine in COPD, as topline results from a Phase 3b study …
AstraZeneca share price: update issued on COPD treatment trial 08/23/2018 majac COPD Biopharmaceutical company, AstraZeneca (LON: ANZ) has this morning announced ‘top-line’ results from trials in patients with the progressive …
Health effects in COPD smokers who switch to electronic cigarettes: a retrospective-prospective 3 … 08/22/2018 majac COPD Background: Health effects of electronic cigarette (EC) use in patients with chronic obstructive pulmonary disease (COPD) are largely unexplored.
Can autoimmunity cause lung disease? 08/19/2018 majac COPD Autoimmunity plays a key role in the development of chronic obstructive pulmonary disease (COPD), a new study has shown. COPD is a group of lung …
